Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virpax Pharmaceuticals Inc (NQ: VRPX )

0.5670 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Virpax Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers SomaLogic (NASDAQ:SLGC) shares mo... 
Via Benzinga
Virpax® Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
From Virpax® Pharmaceuticals, Inc.
Via Business Wire
Virpax Pharmaceuticals Recaps Milestones and Highlights Product Portfolio
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax Announces Clinical Trial Site in Canada for First in Human Study of Epoladerm™ for Pain Associated with Osteoarthritis of the Knee
From Virpax Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares increased by 88.08% to $5.61 during Thursday's regular session. As of 12:30 EST, Ensysce Biosciences's stock is... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's... 
Via Benzinga
Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) reported results following toxicology and pharmacokinetic study of Epoladerm to manage pain associated with... 
Via Benzinga
Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™
From Virpax Pharmaceuticals, Inc.
Via Business Wire
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax Signs Agreement with Sinclair Research to Initiate Investigational New Drug (IND)-Enabling Studies for AnQlar™
From Virpax Pharmaceuticals Inc.
Via Business Wire
Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock
From Virpax Pharmaceuticals Inc.
Via Business Wire
46 Biggest Movers From Yesterday
Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited... 
Via Benzinga
Why Virpax Pharmaceuticals' Stock Is Trading Lower Today
Virpax Pharmaceuticals (NASDAQ:VRPX) shares are trading lower after the company priced a 6.67 million share common stock offering at $6 per share. Virpax Pharmaceuticals... 
Via Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb
Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide
Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
36 Stocks Moving In Tuesday's Mid-Day Session
Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares... 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August
Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock
From Virpax Pharmaceuticals Inc.
Via Business Wire
45 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
21 Stocks Moving in Monday's Pre-Market Session
Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in... 
Via Benzinga
60 Biggest Movers From Friday
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... 
Via Benzinga
Virpax Pharmaceuticals Announces Poster Presentation for Envelta™ at PAINWeek 2021
From Virpax Pharmaceuticals
Via Business Wire
Why Virpax Pharmaceuticals Stock Is Trading Higher Today
Virpax Pharmaceuticals (NASDAQ: VRPX) is trading higher after the company announced it entered into a commercial manufacturing and supply agreement with Seqens. The agreement with... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.